ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
BioXcel Therapeutics Inc

BioXcel Therapeutics Inc (BTAI)

2,70
-1,05
(-28,00%)
Geschlossen 05 März 10:00PM
2,74
0,04
( 1,48% )
Vor Marktöffnung: 10:51AM
Fortg. Diagramm

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
2,74
Gebot
2,70
Fragen
2,89
Volumen
1.371
0,00 Tagesbereich 0,00
1,72 52-Wochen-Bereich 52,80
Marktkapitalisierung
Handelsende
2,70
Handelsbeginn
-
Letzte Trade
1
@
2.79
Letzter Handelszeitpunkt
10:52:12
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
6.394.453
Ausgegebene Aktien
3.101.809
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,05
Gewinn pro Aktie (EPS)
-57,73
Erlöse
1,38M
Nettogewinn
-179,05M

Über BioXcel Therapeutics Inc

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
BioXcel Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BTAI. The last closing price for BioXcel Therapeutics was US$2,70. Over the last year, BioXcel Therapeutics shares have traded in a share price range of US$ 1,72 to US$ 52,80.

BioXcel Therapeutics currently has 3.101.809 shares in issue. The market capitalisation of BioXcel Therapeutics is US$8,37 million. BioXcel Therapeutics has a price to earnings ratio (PE ratio) of -0.05.

BTAI Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.90649.40021810251.8346.831.72503062463.09243058CS
4-2.06-42.91666666674.86.831.72143065383.10216693CS
12-4.46-61.94444444447.29.2561.7263944533.71154831CS
26-7.0856-72.113662279.825613.36161.7231659024.26606641CS
52-46.54-94.439935064949.2852.81.7218393028.0675172CS
156-264.94-98.9763897191267.685461.72145624783.3631508CS
260-462.06-99.4104991394464.81198.241.721045176176.82534829CS

BTAI - Frequently Asked Questions (FAQ)

What is the current BioXcel Therapeutics share price?
The current share price of BioXcel Therapeutics is US$ 2,74
How many BioXcel Therapeutics shares are in issue?
BioXcel Therapeutics has 3.101.809 shares in issue
What is the market cap of BioXcel Therapeutics?
The market capitalisation of BioXcel Therapeutics is USD 8,37M
What is the 1 year trading range for BioXcel Therapeutics share price?
BioXcel Therapeutics has traded in the range of US$ 1,72 to US$ 52,80 during the past year
What is the PE ratio of BioXcel Therapeutics?
The price to earnings ratio of BioXcel Therapeutics is -0,05
What is the cash to sales ratio of BioXcel Therapeutics?
The cash to sales ratio of BioXcel Therapeutics is 6,07
What is the reporting currency for BioXcel Therapeutics?
BioXcel Therapeutics reports financial results in USD
What is the latest annual turnover for BioXcel Therapeutics?
The latest annual turnover of BioXcel Therapeutics is USD 1,38M
What is the latest annual profit for BioXcel Therapeutics?
The latest annual profit of BioXcel Therapeutics is USD -179,05M
What is the registered address of BioXcel Therapeutics?
The registered address for BioXcel Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the BioXcel Therapeutics website address?
The website address for BioXcel Therapeutics is www.bioxceltherapeutics.com
Which industry sector does BioXcel Therapeutics operate in?
BioXcel Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GTIGraphjet Technology
US$ 0,2411
(74,71%)
775,25k
ARBBARB IOT Group Ltd
US$ 0,8838
(69,96%)
5,84M
GITSGlobal Interactive Technologies Inc
US$ 3,61
(60,12%)
71
AGHAureus Greenway Holdings Inc
US$ 1,03
(33,77%)
4,82M
NVNINVNI Group Ltd
US$ 0,3379
(28,72%)
22,94M
SYRESpyre Therapeutics Inc
US$ 13,13
(-27,94%)
1
RETOReTo Eco Solutions Inc
US$ 0,659
(-25,54%)
56,29k
OMCLOmnicell Inc
US$ 28,00
(-25,11%)
392
OMEROmeros Corporation
US$ 6,01
(-24,69%)
8
ARHSArhaus Inc
US$ 7,01
(-24,30%)
5
NVNINVNI Group Ltd
US$ 0,3379
(28,72%)
22,94M
ARBBARB IOT Group Ltd
US$ 0,8838
(69,96%)
5,84M
BTOGBit Origin Ltd
US$ 0,4404
(23,02%)
5,61M
AGHAureus Greenway Holdings Inc
US$ 1,03
(33,77%)
4,82M
SHViShares Short Treasury Bond ETF
US$ 110,135
(0,01%)
4,13M

BTAI Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen